Peripheral Vascular Stent Market : Global Industry Analysis and Opportunity Assessment, 2035
The peripheral vascular stent market is segmented by Product Type (Self-Expanding Stents, Balloon-Expanding Stents, Covered Stents, Drug-Eluting Stents), Artery Type (Carotid Artery, Fem-Pop Artery, Iliac Artery, Infrapop Artery), and End User (Hospitals, Ambulatory Surgical Centers/Outpatients). Forecast for 2026 to 2036.
- Industry Size (2025): USD 4.59 Bn
- Forecast (2035): USD 9.55 Bn
- CAGR (2025 to 2035): 7.6%
Peripheral Vascular Stent Market Size, Market Forecast and Outlook By FMI
The peripheral vascular stent market is expected to expand from USD 4.94 billion in 2026 to USD 10.28 billion by 2036. The market is anticipated to register a 7.6% CAGR during the forecast period. Self-expanding stents are likely to lead with a 53.1% share, and iliac artery stents are projected to account for 48.0% of artery type demand in 2026.
Summary of the Peripheral Vascular Stent Market
- Demand and Growth Drivers
- Rising peripheral artery disease incidence is expected to increase procedure volumes across hospitals and outpatient vascular care settings.
- Aging populations and diabetes prevalence are likely to raise demand for minimally invasive peripheral artery treatment options.
- Device improvements are anticipated to increase physician confidence in stenting for complex lower-extremity vascular lesions.
- Product and Segment View
- Self-expanding stents are expected to lead the product type segment through flexible deployment in peripheral vessel anatomy.
- Iliac artery stents are likely to see strong use as clinicians need high radial strength for larger vessels.
- Drug-eluting stents are anticipated to gain attention as restenosis prevention becomes a stronger clinical priority.
- Geography and Competitive Outlook
- China is expected to lead country-level expansion as cardiovascular disease burden and device access increase together.
- India is likely to record steady adoption as peripheral angioplasty use expands across advanced care centers.
- Manufacturers with stronger clinical evidence and broader stent portfolios are anticipated to strengthen physician preference.
- Analyst Opinion
- Sabyasachi Ghosh, Principal Consultant for Healthcare at FMI, suggests, “The peripheral vascular stent market is expected to favor manufacturers able to combine vessel-specific design with reliable clinical evidence. Companies investing in flexible stent platforms and outpatient-ready vascular solutions are likely to gain stronger acceptance across interventional care settings.”
- Peripheral Vascular Stent Market Value Analysis
- The peripheral vascular stent market is moving toward minimally invasive vascular care across hospital and outpatient settings.
- Demand is likely to rise as peripheral artery disease treatment shifts toward earlier intervention and better vessel patency.
- Adoption is expected to gain momentum through improved stent flexibility and stronger physician familiarity with endovascular procedures.
- Spending is anticipated to be backed by aging populations and higher use of advanced vascular intervention technologies.
Peripheral Vascular Stent Market Analyzed by Top Investment Segments
The market is segmented based on product type, artery type, end user, and region. By product type, the market is divided into self-expanding stents, balloon-expanding stents, covered stents, and drug-eluting stents. In terms of artery type, it is segmented into carotid artery, fem-pop artery, iliac artery, and infrapop artery.
Based on end user, the market is categorized into hospitals and ambulatory surgical centres/outpatients. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and the Middle East and Africa.
By Product Type, Drug-Eluting Stents to Drive Advanced Vascular Treatments
Self-expanding stents segment holds 53.1% market share in 2025. The drug-eluting stents segment is witnessing increasing demand due to their ability to reduce restenosis and improve long-term vascular outcomes, making them the preferred choice for complex peripheral artery disease interventions.
These stents release therapeutic agents that inhibit neointimal hyperplasia, improving vessel patency. Increasing adoption is driven by clinical trials supporting their efficacy in fem-pop and below-the-knee interventions, especially in aging populations with comorbidities like diabetes. Technological advancements, including next-generation bioresorbable polymers and tailored drug coatings, are further enhancing their market potential.
Self-expanding stents continue to dominate volume-wise due to their flexibility and ability to adapt to peripheral vessel anatomy. Balloon-expanding stents are preferred in cases requiring precise deployment and high radial strength, particularly in iliac arteries. Covered stents remain vital for complex lesions and aneurysm repair, offering protection against vessel rupture and perforation.
While each stent type has a defined clinical role, the accelerating demand for drug-eluting stents, backed by strong clinical data and improving reimbursement scenarios, is reshaping the competitive landscape of peripheral vascular interventions.
| Product Type | Share (2025) |
|---|---|
| Self-expanding Stents | 53.1% |
By Artery Type, Fem-Pop Artery Segment to Gain Clinical Preference
Iliac artery segment holds 48% market share in 2025. The fem-pop artery segment is witnessing strong demand growth, driven by the rising incidence of peripheral artery disease (PAD), particularly in the elderly and diabetic populations. The femoral-popliteal segment is highly susceptible to atherosclerotic plaque buildup, creating sustained demand for advanced stent solutions.
Recent innovations in stent flexibility, fracture resistance, and drug delivery are enabling better outcomes in this challenging arterial zone. Moreover, the shift toward minimally invasive endovascular procedures are promoting the use of drug-eluting stents and next-generation self-expanding devices in the fem-pop segment.
The carotid artery segment remains critical for stroke prevention, supported by steady demand for stenting as an alternative to carotid endarterectomy. Iliac artery interventions continue to see strong uptake, particularly in cases requiring high radial force and large-diameter stents.
The infrapop artery segment is growing steadily as well, driven by increasing clinical attention to below-the-knee revascularization in critical limb ischemia cases. Across all segments, fem-pop artery stents are emerging as the innovation focal point, driven by the complex biomechanics and high restenosis risks associated with this anatomical region.
| Artery Type | Share (2025) |
|---|---|
| Iliac Artery | 48% |
By End User, Ambulatory Surgical Centers to Witness Rapid Uptake
Ambulatory surgical centers/outpatients are projected to grow at the CAGR of 7.9% from 2025 to 2035. This trend is fueled by the healthcare industry's ongoing shift toward outpatient vascular interventions. ASCs offer cost-effective, patient-friendly alternatives to traditional hospital-based procedures.
Advances in device technology and post-procedure management are making same-day discharge increasingly viable for peripheral stenting. Additionally, favorable reimbursement policies and growing ASC networks across the USA and Europe are accelerating the transition of endovascular procedures to outpatient settings.
Hospitals, however, remain the primary treatment centers for complex peripheral interventions and emergency cases. They continue to dominate the market in terms of overall volume, owing to the availability of advanced imaging, hybrid ORs, and multidisciplinary vascular care teams. Hospitals also cater to high-risk patients who require comprehensive perioperative monitoring. While ASCs lead growth, the complementary roles of both settings are vital in broadening patient access to peripheral vascular stenting solutions.
| End User | CAGR (2025 to 2035) |
|---|---|
| Ambulatory Surgical Centers/Outpatients | 7.9% |
Peripheral Vascular Stent Sector Trends and Emerging Opportunities
- Surging consumer preference for drug-eluting stents due to increasing cardiovascular surgeries is expanding the scope of the peripheral vascular stent industry.
- Rising incidences of peripheral arterial disease (PAD) and increasing obesity-inflicted population.
- Technological advancements by market players are enhancing the design and functionality of these stents.
- Manufacturers are contributing to market growth by conducting investigational studies to expand the treatment options for patients suffering from peripheral arterial disease.
- Growing research body on the safety and efficacy of peripheral vascular intervention devices.
Peripheral Vascular Stent Market Demand Analysis by Country
| Countries | Forecast CAGR (2025 to 2035) |
|---|---|
| The United States | 5.90% |
| The United Kingdom | 6.40% |
| GCC Countries | 7.60% |
| China | 10.30% |
| India | 7.10% |
The United States is Expected to Remain at the Forefront of Peripheral Vascular Stents Market
The demand for peripheral vascular stents in the United States is estimated to assume a pace of 5.90% CAGR over the upcoming decade. The chief factor that is driving the United States market is the broad availability of newly approved drug-eluting stents across the country.
The United States market wields substantial power in North America as it stands at the forefront and determines the region’s growth. Fundamental drivers that are supporting the market’s expansion include the expanding geriatric population and the prevailing utilization of peripheral stent implants. Surging acceptance of minimally invasive procedures for cardiovascular disorders is another contributing factor.
The rising presence of peripheral vascular stent providers is compelling market growth. Additionally, the approval and early availability of the latest, technologically progressive stents have also transformed the peripheral vascular stents market landscape. These include bio-absorbable and drug-eluting stents.
Research Studies in Stents to Promote the United Kingdom Market
The United Kingdom peripheral vascular stent market is projected to expand at a CAGR of 6.40% over the forecast period. The market is supposed to grow in the United Kingdom as a result of increasing studies to widen the scope of peripheral arterial disease treatment options.
For instance, in May 2025, BD, a prominent medical technology player, announced the first patient enrollment in the investigational device exemption (IDE) study called “AGILITY”. The study assesses the effectiveness and safety of the BD Vascular Covered Stent for the Peripheral Arterial Disease (PAD) treatment.
The company stated that the global, non-randomized, multi-center, prospective, single-arm AGILITY clinical study is expected to include 315 patients. The study encompasses 40 clinical study sites throughout Europe, the United States, New Zealand, and Australia.
India to Observe Increasing Popularity of Latest Equipment for Peripheral Vascular Disease Treatment
The sale of peripheral vascular stent in India is expected to increase at a CAGR of 7.10% over the forecast period. The market is propelled by the expanding patient pool and increasing elderly population who are susceptible to chronic illnesses.
Surging adoption of peripheral angioplasty, the rising presence of cost-effective surgeries, and enhancing immunization access are some common contributory factors that are propelling market growth.
Indian players are actively contributing to the advancement of this industry. For example, Concept Medical Inc., an MNC for medical devices founded by Manish Doshi. The MNC made headlines with Concept Medical’s MagicTouch in a confluence of acclaimed Indian and foreign doctors which was held in Surat in January 2025. Concept Medical’s MagicTouch is the world’s first Sirolimus-coated balloon.
The product is becoming commercial just in time to offer a ray of hope for millions of people inflicted with peripheral vascular disease (PVD). In this confluence, doctors came together to discuss the latest advancements in vascular medicine, effective patient relief measures, and strategies for halting PVD development.
Chinese Market to Expand Rapidly Over the Next Decade
The peripheral vascular stent market in China is predicted to expand at an impressive CAGR of 10.30% over the forecast period. A growing patient base for people suffering from high-risk cardiovascular diseases is a key determiner for the use of stents to treat obstructive coronary diseases.
The primary strategy adopted by domestic players in China is the affordable cost of stents. Additionally, key players in the industry are persistently developing distinct and groundbreaking stent technologies to help them obtain a leading market position.
Biotronik had revealed in the historical period that its new Orsiro DES has gained approval for sale by the National Medical Products Administration in the country. This move means that the firm will be able to make the stent available for patients and medical practitioners in a matter of months.
Vendors in GCC Countries to Use Latest Technologies to Attract New Customers
The peripheral vascular stent market in GCC countries is expected to increase at 7.60% CAGR over the next decade. Poor knowledge about peripheral artery diseases (PAD) among the high-risk individuals residing in GCC countries is increasing the risk of PADs in these countries.
Industry participants are also using this knowledge gap to target their educational campaigns, especially among high-risk populations. Players are enhancing their portfolios by investing in new technologies. Furthermore, advancements supported by modern technologies are expected to introduce the latest trends in the market across GCC countries.
Competitive Landscape in the Peripheral Vascular Stent Market
Biosensors, Abbott, Boston Scientific, Biotronik, Stryker, Medtronic, Terumo, and B. Braun are identified as powerful players in the peripheral vascular stent market. Their growth is stimulated by the increasing count of cardiovascular surgeries performed alongside minimally invasive techniques.
Medical equipment manufacturers are using market penetrative strategies to gain a large foothold in the industry. The launch of the self-expanding Eluvia drug-eluting stent (DES) system, in the historical period, is a top strategy adopted by market players. This launch served a double benefit as it helped the company extend its PAD portfolio as well as utilize a new drug-polymer combination for the sustained release of the drug paclitaxel.
In the quest to gain a larger foothold in the market, stent makers and medical device manufacturers are investing in research and innovations to elevate their portfolios. ETH Zurich researchers have released a new method to develop malleable microstructure production utilizing indirect 4-D printing.
This latest technology has the potential to develop malleable microstructure production utilizing indirect 4-D printing. Moreover, the government support for certain studied and analyzed product offerings is also encouraging players to expand in this market.
In emerging markets, stent manufacturers are acquiring and merging with other competing players to enhance their position.
News Coverage of Peripheral Vascular Stent Market
- In May 2023, the microcatheter Vericor-14 of Acotec Scientific Holdings Ltd. attained Chinese approval for interventional treatment. Their use will be widespread in the treatment of percutaneous peripheral and percutaneous coronary interventions.
- In March 2024, Becton, Dickinson, and Company (BD) introduced a peripheral arterial disease (PAD) treatment study with a vascular-covered stent as the focus. The stent is a self-expanding, low-profile, polytetrafluoroethylene encapsulated nitinol implant.
- In November 2019, Sahajanand Medical Technologies (SMT), an Indian stent manufacturer, acquired a majority stake in Zarek Distribuidora De Produtos Hospitalares, a Brazilian sales and marketing company. This endeavor is predicted to be fruitful for SMT, taking into consideration that Brazil is a top destination for interventional cardiology. This alliance is expected to permit SMT to form a strong overseas presence not only in Brazil but also in other countries of Latin America. These include Columbia, Bolivia, Argentina, and Venezuela to name a few.
Key Coverage in the Global Peripheral Vascular Stent Indsutry Research Report
- Adjacent Study of Medical Devices Industry and Medical Equipment Manufacturing Market
- Market Analysis of Distribution Channels for Medical Devices
- Impact of Healthcare Policies on Peripheral Vascular Stent Market
- Peripheral Vascular Stent Industry Value, Share and Size Analysis
- Stent Industry Progression Assessment
Enlisted Below are Some Top Market Players
- Medtronic Plc.
- Cardinal Health, Inc.
- B. Braun Melsungen AG
- MicroPort Scientific Corporation
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- Abbott Laboratories
- W.L. Gore & Associates Inc.
- Cook Medical Inc.
- Others
Report Coverage for Global Peripheral Vascular Stent Market
| Attribute | Details |
|---|---|
| Current Total Market Size (2025) | USD 4.59 billion |
| Projected Market Size (2035) | USD 9.55 billion |
| CAGR (2025 to 2035) | 7.6% |
| Base Year for Estimation | 2024 |
| Historical Period | 2020 to 2024 |
| Projections Period | 2025 to 2035 |
| Report Parameter | Revenue in USD billion/volume in units |
| By Product Type | Self-Expanding Stents, Balloon-Expanding Stents, Covered Stents, and Drug-Eluting Stents |
| By Artery Type | Carotid Artery, Fem-Pop Artery, Iliac Artery, and Infrapop Artery |
| By End User | Hospitals and Ambulatory Surgical Centres/Outpatients |
| Regions Covered | North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, Middle East and Africa |
| Countries Covered | United States, United Kingdom, GCC Countries, China, India |
| Key Players | Medtronic Plc., Cardinal Health, Inc., B. Braun Melsungen AG, MicroPort Scientific Corporation, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Abbott Laboratories, W.L. Gore & Associates Inc., Cook Medical Inc. |
| Additional Attributes | Dollar sales by value, market share analysis by region, and country-wise analysis |
Market Segmentation of Peripheral Vascular Stent
By Product Type:
- Self-Expanding Stents
- Balloon-Expanding Stents
- Covered Stents
- Drug-Eluting Stents
By Artery Type:
- Carotid Artery
- Fem-Pop Artery
- Iliac Artery
- Infrapop Artery
By End User:
- Hospitals
- Ambulatory Surgical Centers/Outpatients
By Regional:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Frequently Asked Questions
What is the projected size of the peripheral vascular stent market by 2035?
The market is projected to reach USD 9.55 billion by 2035, growing from USD 4.59 billion in 2025, at a CAGR of 7.6%.
Which product segment is growing the fastest in the peripheral vascular stent market?
The drug-eluting stents segment is growing the fastest, with a CAGR of 8.1%.
Which end user segment contributes most to the growth of the peripheral vascular stent market?
The ambulatory surgical centers/outpatients segment is slated to grow at 7.9% CAGR during the study period.
What are the major factors driving demand for peripheral vascular stents globally?
Key drivers include rising PAD incidence, aging populations, diabetes prevalence, and innovations in stent technologies.
Who are the leading players in the global peripheral vascular stent market?
Top players include Medtronic Plc, Cardinal Health, Inc., B. Braun Melsungen AG, and Boston Scientific Corporation.
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2020 to 2024 and Forecast, 2025 to 2035
- 5. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Product Type
- 5.1. Self-Expanding Stents
- 5.2. Balloon-Expanding Stents
- 5.3. Covered Stents
- 5.4. Drug-Eluting Stents
- 6. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Artery Type
- 6.1. Carotid Artery
- 6.2. Fem-Pop Artery
- 6.3. Iliac Artery
- 6.4. Infrapop Artery
- 7. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By End User
- 7.1. Hospitals
- 7.2. Ambulatory Surgical Centres/Outpatients
- 8. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Western Europe
- 8.4. Eastern Europe
- 8.5. South Asia and Pacific
- 8.6. East Asia
- 8.7. Middle East and Africa
- 9. North America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- 10. Latin America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- 11. Western Europe Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- 12. Eastern Europe Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- 13. South Asia and Pacific Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- 14. East Asia Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- 15. Middle East and Africa Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- 16. Key Countries Market Analysis
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1. Medtronic Plc.
- 18.2. Cardinal Health, Inc.
- 18.3. B. Braun Melsungen AG
- 18.4. MicroPort Scientific Corporation
- 18.5. Boston Scientific Corporation
- 18.6. BIOTRONIK SE & Co. KG
- 18.7. Abbott Laboratories
- 18.8. W.L. Gore & Associates Inc.
- 18.9. Cook Medical Inc.
- 19. Assumptions & Acronyms Used
- 20. Research Methodology
